Annual FCF
-$772.77 M
-$263.85 M-51.85%
31 December 2023
Summary:
Novavax annual free cash flow is currently -$772.77 million, with the most recent change of -$263.85 million (-51.85%) on 31 December 2023. During the last 3 years, it has fallen by -$675.61 million (-695.34%). NVAX annual FCF is now -391.11% below its all-time high of $265.46 million, reached on 31 December 2021.NVAX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$146.83 M
-$457.97 M-147.19%
30 September 2024
Summary:
Novavax quarterly free cash flow is currently -$146.83 million, with the most recent change of -$457.97 million (-147.19%) on 30 September 2024. Over the past year, it has dropped by -$88.78 million (-152.95%). NVAX quarterly FCF is now -122.61% below its all-time high of $649.30 million, reached on 31 March 2021.NVAX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$112.35 M
-$88.78 M-376.73%
30 September 2024
Summary:
Novavax TTM free cash flow is currently -$112.35 million, with the most recent change of -$88.78 million (-376.73%) on 30 September 2024. Over the past year, it has increased by +$614.45 million (+84.54%). NVAX TTM FCF is now -118.95% below its all-time high of $592.76 million, reached on 30 June 2021.NVAX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.9% | -152.9% | +84.5% |
| 3 y3 years | -695.3% | +4.9% | -124.8% |
| 5 y5 years | -315.0% | -350.1% | +29.9% |
NVAX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -391.1% | at low | -147.2% | +59.1% | -124.8% | +86.2% |
| 5 y | 5 years | -391.1% | at low | -122.6% | +59.1% | -119.0% | +86.2% |
| alltime | all time | -391.1% | at low | -122.6% | +59.1% | -119.0% | +86.2% |
Novavax Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$146.83 M(-147.2%) | -$112.35 M(+376.7%) |
| June 2024 | - | $311.14 M(-442.7%) | -$23.57 M(-95.4%) |
| Mar 2024 | - | -$90.81 M(-51.1%) | -$514.43 M(-33.4%) |
| Dec 2023 | -$772.77 M(+51.8%) | -$185.86 M(+220.2%) | -$772.77 M(+6.3%) |
| Sept 2023 | - | -$58.05 M(-67.7%) | -$726.79 M(-1.4%) |
| June 2023 | - | -$179.72 M(-48.5%) | -$736.98 M(-2.1%) |
| Mar 2023 | - | -$349.15 M(+149.6%) | -$752.74 M(+47.9%) |
| Dec 2022 | -$508.92 M(-291.7%) | -$139.88 M(+105.0%) | -$508.92 M(-30.1%) |
| Sept 2022 | - | -$68.23 M(-65.1%) | -$727.81 M(-10.6%) |
| June 2022 | - | -$195.48 M(+85.6%) | -$813.92 M(+66.4%) |
| Mar 2022 | - | -$105.34 M(-70.6%) | -$489.18 M(-284.3%) |
| Dec 2021 | $265.46 M(-373.2%) | -$358.77 M(+132.5%) | $265.46 M(-41.5%) |
| Sept 2021 | - | -$154.33 M(-219.4%) | $453.65 M(-23.5%) |
| June 2021 | - | $129.26 M(-80.1%) | $592.76 M(+3.0%) |
| Mar 2021 | - | $649.30 M(-480.6%) | $575.37 M(-692.2%) |
| Dec 2020 | -$97.16 M(-29.8%) | -$170.58 M(+1020.5%) | -$97.16 M(-296.5%) |
| Sept 2020 | - | -$15.22 M(-113.6%) | $49.46 M(+54.3%) |
| June 2020 | - | $111.87 M(-581.5%) | $32.06 M(-129.1%) |
| Mar 2020 | - | -$23.23 M(-3.0%) | -$110.30 M(-20.3%) |
| Dec 2019 | -$138.48 M(-25.6%) | -$23.96 M(-26.5%) | -$138.48 M(-13.6%) |
| Sept 2019 | - | -$32.62 M(+7.0%) | -$160.30 M(-0.8%) |
| June 2019 | - | -$30.49 M(-40.7%) | -$161.59 M(-5.7%) |
| Mar 2019 | - | -$51.41 M(+12.3%) | -$171.38 M(-8.0%) |
| Dec 2018 | -$186.20 M(+25.2%) | -$45.78 M(+35.0%) | -$186.20 M(+0.9%) |
| Sept 2018 | - | -$33.91 M(-15.8%) | -$184.46 M(-5.9%) |
| June 2018 | - | -$40.28 M(-39.2%) | -$195.95 M(+15.7%) |
| Mar 2018 | - | -$66.22 M(+50.4%) | -$169.31 M(+13.9%) |
| Dec 2017 | -$148.66 M(-46.3%) | -$44.05 M(-3.0%) | -$148.66 M(-13.7%) |
| Sept 2017 | - | -$45.40 M(+232.9%) | -$172.36 M(-10.8%) |
| June 2017 | - | -$13.64 M(-70.1%) | -$193.28 M(-21.8%) |
| Mar 2017 | - | -$45.58 M(-32.7%) | -$247.20 M(-10.7%) |
| Dec 2016 | -$276.97 M(+91.9%) | -$67.74 M(+2.1%) | -$276.97 M(+3.1%) |
| Sept 2016 | - | -$66.32 M(-1.8%) | -$268.60 M(+14.2%) |
| June 2016 | - | -$67.56 M(-10.3%) | -$235.22 M(+27.6%) |
| Mar 2016 | - | -$75.35 M(+26.9%) | -$184.35 M(+27.7%) |
| Dec 2015 | -$144.36 M(+94.3%) | -$59.37 M(+80.3%) | -$144.36 M(+34.7%) |
| Sept 2015 | - | -$32.94 M(+97.2%) | -$107.15 M(+15.1%) |
| June 2015 | - | -$16.70 M(-52.8%) | -$93.12 M(+5.4%) |
| Mar 2015 | - | -$35.35 M(+59.5%) | -$88.32 M(+18.9%) |
| Dec 2014 | -$74.28 M(+45.2%) | -$22.16 M(+17.2%) | -$74.28 M(+13.6%) |
| Sept 2014 | - | -$18.91 M(+58.9%) | -$65.41 M(+3.8%) |
| June 2014 | - | -$11.90 M(-44.2%) | -$62.99 M(+4.4%) |
| Mar 2014 | - | -$21.32 M(+60.5%) | -$60.34 M(+18.0%) |
| Dec 2013 | -$51.14 M(+126.6%) | -$13.29 M(-19.4%) | -$51.14 M(+18.3%) |
| Sept 2013 | - | -$16.48 M(+78.3%) | -$43.25 M(+33.0%) |
| June 2013 | - | -$9.25 M(-23.7%) | -$32.52 M(+9.5%) |
| Mar 2013 | - | -$12.13 M(+124.9%) | -$29.70 M(+31.6%) |
| Dec 2012 | -$22.57 M(-6.9%) | -$5.39 M(-6.4%) | -$22.57 M(+11.5%) |
| Sept 2012 | - | -$5.76 M(-10.5%) | -$20.24 M(+12.2%) |
| June 2012 | - | -$6.43 M(+28.8%) | -$18.04 M(-10.4%) |
| Mar 2012 | - | -$4.99 M(+62.9%) | -$20.15 M(-16.9%) |
| Dec 2011 | -$24.24 M(-29.6%) | -$3.06 M(-13.8%) | -$24.24 M(-10.6%) |
| Sept 2011 | - | -$3.56 M(-58.3%) | -$27.11 M(-16.8%) |
| June 2011 | - | -$8.54 M(-6.0%) | -$32.59 M(-2.6%) |
| Mar 2011 | - | -$9.08 M(+52.9%) | -$33.45 M(-2.8%) |
| Dec 2010 | -$34.41 M | -$5.94 M(-34.2%) | -$34.41 M(-16.6%) |
| Sept 2010 | - | -$9.03 M(-4.0%) | -$41.24 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | -$9.40 M(-6.3%) | -$38.82 M(+5.4%) |
| Mar 2010 | - | -$10.04 M(-21.4%) | -$36.82 M(+9.7%) |
| Dec 2009 | -$33.58 M(+11.9%) | -$12.78 M(+93.4%) | -$33.58 M(+19.2%) |
| Sept 2009 | - | -$6.61 M(-10.8%) | -$28.16 M(-14.0%) |
| June 2009 | - | -$7.41 M(+9.1%) | -$32.75 M(+9.3%) |
| Mar 2009 | - | -$6.79 M(-7.7%) | -$29.96 M(-0.1%) |
| Dec 2008 | -$30.00 M(+4.5%) | -$7.36 M(-34.3%) | -$30.00 M(+6.2%) |
| Sept 2008 | - | -$11.20 M(+142.8%) | -$28.25 M(+6.1%) |
| June 2008 | - | -$4.61 M(-32.5%) | -$26.63 M(-5.9%) |
| Mar 2008 | - | -$6.83 M(+21.9%) | -$28.28 M(-1.5%) |
| Dec 2007 | -$28.70 M(+77.0%) | -$5.61 M(-41.5%) | -$28.70 M(+11.3%) |
| Sept 2007 | - | -$9.57 M(+52.7%) | -$25.79 M(+29.4%) |
| June 2007 | - | -$6.27 M(-13.6%) | -$19.93 M(+5.4%) |
| Mar 2007 | - | -$7.25 M(+169.4%) | -$18.91 M(+16.6%) |
| Dec 2006 | -$16.22 M(+174.0%) | -$2.69 M(-27.5%) | -$16.22 M(+179.0%) |
| Sept 2006 | - | -$3.71 M(-29.4%) | -$5.81 M(+99.6%) |
| June 2006 | - | -$5.26 M(+15.4%) | -$2.91 M(+38.3%) |
| Mar 2006 | - | -$4.55 M(-159.1%) | -$2.11 M(-64.4%) |
| Dec 2005 | -$5.92 M(-81.3%) | $7.71 M(-1049.6%) | -$5.92 M(-74.5%) |
| Sept 2005 | - | -$812.00 K(-81.8%) | -$23.21 M(-29.4%) |
| June 2005 | - | -$4.45 M(-46.8%) | -$32.88 M(-5.0%) |
| Mar 2005 | - | -$8.37 M(-12.6%) | -$34.60 M(+9.1%) |
| Dec 2004 | -$31.71 M(+62.1%) | -$9.58 M(-8.7%) | -$31.71 M(+19.9%) |
| Sept 2004 | - | -$10.48 M(+70.0%) | -$26.45 M(+35.0%) |
| June 2004 | - | -$6.17 M(+12.6%) | -$19.59 M(+0.0%) |
| Mar 2004 | - | -$5.48 M(+26.9%) | -$19.58 M(+0.1%) |
| Dec 2003 | -$19.57 M(-36.3%) | -$4.32 M(+19.2%) | -$19.57 M(-4.4%) |
| Sept 2003 | - | -$3.62 M(-41.2%) | -$20.47 M(-18.6%) |
| June 2003 | - | -$6.16 M(+12.7%) | -$25.13 M(-3.9%) |
| Mar 2003 | - | -$5.46 M(+4.7%) | -$26.15 M(-14.9%) |
| Dec 2002 | -$30.73 M(+345.3%) | -$5.22 M(-37.0%) | -$30.73 M(+4.3%) |
| Sept 2002 | - | -$8.29 M(+15.4%) | -$29.45 M(+30.7%) |
| June 2002 | - | -$7.18 M(-28.5%) | -$22.53 M(+61.5%) |
| Mar 2002 | - | -$10.04 M(+154.8%) | -$13.95 M(+102.1%) |
| Dec 2001 | -$6.90 M(-36.5%) | -$3.94 M(+187.2%) | -$6.90 M(+6.0%) |
| Sept 2001 | - | -$1.37 M(-197.9%) | -$6.51 M(-19.2%) |
| June 2001 | - | $1.40 M(-146.9%) | -$8.06 M(-32.2%) |
| Mar 2001 | - | -$2.99 M(-15.8%) | -$11.89 M(+9.4%) |
| Dec 2000 | -$10.88 M(+193.9%) | -$3.55 M(+21.6%) | -$10.88 M(+54.8%) |
| Sept 2000 | - | -$2.92 M(+20.2%) | -$7.02 M(+19.0%) |
| June 2000 | - | -$2.43 M(+23.2%) | -$5.90 M(+16.4%) |
| Mar 2000 | - | -$1.97 M(-757.7%) | -$5.07 M(+37.1%) |
| Dec 1999 | -$3.70 M(-2.6%) | $300.00 K(-116.7%) | -$3.70 M(-24.5%) |
| Sept 1999 | - | -$1.80 M(+12.5%) | -$4.90 M(+14.0%) |
| June 1999 | - | -$1.60 M(+166.7%) | -$4.30 M(+19.4%) |
| Mar 1999 | - | -$600.00 K(-33.3%) | -$3.60 M(-5.3%) |
| Dec 1998 | -$3.80 M(-9.5%) | -$900.00 K(-25.0%) | -$3.80 M(-5.0%) |
| Sept 1998 | - | -$1.20 M(+33.3%) | -$4.00 M(+2.6%) |
| June 1998 | - | -$900.00 K(+12.5%) | -$3.90 M(0.0%) |
| Mar 1998 | - | -$800.00 K(-27.3%) | -$3.90 M(-7.1%) |
| Dec 1997 | -$4.20 M(+23.5%) | -$1.10 M(0.0%) | -$4.20 M(+5.0%) |
| Sept 1997 | - | -$1.10 M(+22.2%) | -$4.00 M(+8.1%) |
| June 1997 | - | -$900.00 K(-18.2%) | -$3.70 M(0.0%) |
| Mar 1997 | - | -$1.10 M(+22.2%) | -$3.70 M(+12.1%) |
| Dec 1996 | -$3.40 M | -$900.00 K(+12.5%) | -$3.30 M(+37.5%) |
| Sept 1996 | - | -$800.00 K(-11.1%) | -$2.40 M(+50.0%) |
| June 1996 | - | -$900.00 K(+28.6%) | -$1.60 M(+128.6%) |
| Mar 1996 | - | -$700.00 K | -$700.00 K |
FAQ
- What is Novavax annual free cash flow?
- What is the all time high annual FCF for Novavax?
- What is Novavax annual FCF year-on-year change?
- What is Novavax quarterly free cash flow?
- What is the all time high quarterly FCF for Novavax?
- What is Novavax quarterly FCF year-on-year change?
- What is Novavax TTM free cash flow?
- What is the all time high TTM FCF for Novavax?
- What is Novavax TTM FCF year-on-year change?
What is Novavax annual free cash flow?
The current annual FCF of NVAX is -$772.77 M
What is the all time high annual FCF for Novavax?
Novavax all-time high annual free cash flow is $265.46 M
What is Novavax annual FCF year-on-year change?
Over the past year, NVAX annual free cash flow has changed by -$263.85 M (-51.85%)
What is Novavax quarterly free cash flow?
The current quarterly FCF of NVAX is -$146.83 M
What is the all time high quarterly FCF for Novavax?
Novavax all-time high quarterly free cash flow is $649.30 M
What is Novavax quarterly FCF year-on-year change?
Over the past year, NVAX quarterly free cash flow has changed by -$88.78 M (-152.95%)
What is Novavax TTM free cash flow?
The current TTM FCF of NVAX is -$112.35 M
What is the all time high TTM FCF for Novavax?
Novavax all-time high TTM free cash flow is $592.76 M
What is Novavax TTM FCF year-on-year change?
Over the past year, NVAX TTM free cash flow has changed by +$614.45 M (+84.54%)